Barbara Coffey is a Psychiatry physician affiliated with University of Miami. OpenAlex indexes 34 publications with 1,135 citations (h-index 11); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1120 NW 14th St Ste 1455
Miami, FL 331362107
Telephone
305-355-7103Registry record last updated 21 Jul 2022.
Clinical trials
- Guanfacine in Children With Tic Disorders
Sponsor: Yale University
- Omega-3 Fatty Acids in Tourette's Disorder
Sponsor: NYU Langone Health
- Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
Sponsor: NYU Langone Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tris Pharma IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2018–2022 per NIH RePORTER. The latest:
- 7/7-Collaborative genomic studies of Tourette Disorder
University of Miami School of Medicine
FY2022$115,125R01MH115959 - 7-7-Collaborative genomic studies of Tourette Disorder
University of Miami School of Medicine
FY2022$114,437R01MH115959 - 7/7-Collaborative genomic studies of Tourette Disorder
University of Miami School of Medicine
FY2021$115,125R01MH115959
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chapter 64. Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
American Psychiatric Association Publishing eBooks
2024 - NAVIGATING CONSENSUS: EXPLORING CURRENT RESEARCH AND PRINCIPLES FOR INTEGRATING PHARMACOGENETICS IN PEDIATRIC PSYCHOPHARMACOLOGY
Journal of the American Academy of Child & Adolescent Psychiatry
2024 - MOVING BEYOND RED LIGHT, GREEN LIGHT: 2022 UPDATE ON PHARMACOGENETICS AND ITS EMERGING ROLE IN ANTIDEPRESSANT TREATMENT
Journal of the American Academy of Child & Adolescent Psychiatry
2022 - Activation in Children and Adolescents Treated With Selective Serotonin Reuptake Inhibitors
Journal of Clinical Psychopharmacology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”